Home LiteratureArticle Details
PMID: 1316452 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions.

Journal of virology ·Vol. 66 ·No. 6 ·1992-06-00 ·Pages 3355-62

Shah WA, Ambinder RF, Hayward GS, Hayward SD

Abstract

The Epstein-Barr virus nuclear antigen EBNA-1 is essential for replication of the viral DNA during latency. EBNA-1 binds as a dimer to palindromic recognition sequences within the plasmid origin of replication, ori-P. In this study, proteinase K susceptibility has been used to further characterize the DNA-binding domain of EBNA-1. Limited protease digestion of EBNA-1 (amino acids 408 to 641) generated a smaller DNA-binding species that had a degree of inherent protease resistance. When EBNA-1 was preincubated with a specific DNA probe, the protease resistance of the smaller binding species increased 100-fold, suggesting that the conformation of EBNA-1 changes on binding. The protease-resistant species comprised an 18-kDa polypeptide that was further cleaved at high levels of protease to 11- and 5.4-kDa products. A model of the proposed protease-resistant domain structure is presented. Constructions carrying serial, internal deletions across the 18-kDa domain were created. Each of the deletions perturbed dimerization ability and abolished DNA binding. These studies suggest that the DNA-binding and dimerization motifs of EBNA-1 lie within a conformationally discrete domain whose overall integrity is necessary for EBNA-1-DNA interaction.

MeSH Terms
Antigens, Viral/drug effects,metabolism DNA Mutational Analysis DNA, Viral/metabolism DNA-Binding Proteins/drug effects,metabolism Endopeptidase K Epstein-Barr Virus Nuclear Antigens Herpesvirus 4, Human/drug effects,metabolism Models, Biological Nucleic Acid Conformation Regulatory Sequences, Nucleic Acid/genetics Serine Endopeptidases/pharmacology
Chemicals
Antigens, Viral DNA, Viral DNA-Binding Proteins Epstein-Barr Virus Nuclear Antigens Serine Endopeptidases Endopeptidase K
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Shah W A
Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland 21205.
Ambinder R F
Hayward G S
Hayward S D
References (38)
38 references, click to expand
  1. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site.
    Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6343-7 PMID: 1648738
  2. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.
    Proc Natl Acad Sci U S A. 1984 Jun;81(12):3806-10 PMID: 6328526
  3. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1.
    J Virol. 1991 Mar;65(3):1466-78 PMID: 1847464
  4. Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus.
    J Biol Chem. 1991 Apr 25;266(12):7819-26 PMID: 1850421
  5. Two distinct domains in the yeast transcription factor IID and evidence for a TATA box-induced conformational change.
    Mol Cell Biol. 1991 Jan;11(1):63-74 PMID: 1986253
  6. Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins.
    Science. 1991 Mar 1;251(4997):1067-71 PMID: 1998122
  7. Folding transition in the DNA-binding domain of GCN4 on specific binding to DNA.
    Nature. 1990 Oct 11;347(6293):575-8 PMID: 2145515
  8. Identification of precursor to cytomegalovirus capsid assembly protein and evidence that processing results in loss of its carboxy-terminal end.
    J Virol. 1990 Mar;64(3):1241-9 PMID: 2154607
  9. The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif.
    J Virol. 1990 Jul;64(7):3358-69 PMID: 2161945
  10. Lambda repressor: a model system for understanding protein-DNA interactions and protein stability.
    Adv Protein Chem. 1990;40:1-61 PMID: 2195849
  11. Evidence of changes in protease sensitivity and subunit exchange rate on DNA binding by C/EBP.
    Science. 1990 Aug 17;249(4970):771-4 PMID: 2202050
  12. Bending of DNA by gene-regulatory proteins: construction and use of a DNA bending vector.
    Gene. 1989 Dec 21;85(1):15-23 PMID: 2533576
  13. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection.
    J Virol. 1989 Jun;63(6):2644-9 PMID: 2542577
  14. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication.
    Cell. 1989 Aug 11;58(3):527-35 PMID: 2547525
  15. High-resolution footprints of the DNA-binding domain of Epstein-Barr virus nuclear antigen 1.
    Mol Cell Biol. 1989 Jun;9(6):2738-42 PMID: 2548088
  16. Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1).
    Nucleic Acids Res. 1988 Apr 25;16(8):3415-35 PMID: 2836795
  17. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.
    Nature. 1985 Feb 28-Mar 6;313(6005):812-5 PMID: 2983224
  18. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
    Mol Cell Biol. 1986 Nov;6(11):3838-46 PMID: 3025615
  19. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins.
    Science. 1988 Jun 24;240(4860):1759-64 PMID: 3289117
  20. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  21. Evidence that the leucine zipper is a coiled coil.
    Science. 1989 Jan 27;243(4890):538-42 PMID: 2911757
  22. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region.
    Cell. 1985 Oct;42(3):859-68 PMID: 2996781
  23. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components.
    Mol Cell Biol. 1985 Aug;5(8):1822-32 PMID: 3018528
  24. Epstein-Barr virus nuclear antigen forms a complex that binds with high concentration dependence to a single DNA-binding site.
    J Virol. 1987 Feb;61(2):465-71 PMID: 3027376
  25. pBD7, a novel cell-free expression vector with efficient translation initiation signal.
    Nucleic Acids Res. 1987 May 11;15(9):3933 PMID: 3675735
  26. DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
    Nature. 1984 Jul 19-25;310(5974):207-11 PMID: 6087149
  27. Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and renaturation of enzymatic activity: results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes.
    Anal Biochem. 1980 Nov 15;109(1):76-86 PMID: 6258458
  28. Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells.
    J Virol. 1992 Feb;66(2):706-14 PMID: 1370554
  29. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells.
    J Virol. 1991 Jan;65(1):483-8 PMID: 1845903
  30. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure.
    Virology. 1991 May;182(1):84-93 PMID: 1850915
  31. X-ray scattering indicates that the leucine zipper is a coiled coil.
    Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):561-4 PMID: 1988953
  32. Altered protein conformation on DNA binding by Fos and Jun.
    Nature. 1990 Oct 11;347(6293):572-5 PMID: 2120592
  33. Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA.
    J Virol. 1990 May;64(5):2369-79 PMID: 2157891
  34. DNA binding-induced conformational change of the yeast transcriptional activator PRTF.
    Cell. 1990 Jul 27;62(2):367-77 PMID: 2164891
  35. Carboxyl-terminal domain of the Epstein-Barr virus nuclear antigen is highly immunogenic in man.
    Proc Natl Acad Sci U S A. 1985 Sep;82(18):6300-4 PMID: 2412231
  36. Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites.
    J Virol. 1989 Jan;63(1):101-10 PMID: 2535719
  37. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.
    J Virol. 1989 Jun;63(6):2657-66 PMID: 2542579
  38. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6550-4 PMID: 1713681
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1992-06-00
Pages
3355-62
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC241114
Subset
IM
Grants
NIAID NIH HHS · K11AI00648 · United States
NCI NIH HHS · R01-CA22130 · United States
NCI NIH HHS · R01-CA42243 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com